Elsevier

Psychiatry Research

Volume 149, Issues 1–3, 15 January 2007, Pages 89-95
Psychiatry Research

Stigma, social function and symptoms in schizophrenia and schizoaffective disorder: Associations across 6 months

https://doi.org/10.1016/j.psychres.2006.03.007Get rights and content

Abstract

Research suggests stigma is a barrier to self-esteem and the attainment of resources in schizophrenia. Less clear is the association of stigma experiences with symptoms and social function both concurrently and prospectively. To assess this, symptoms were measured using the Positive and Negative Syndrome Scale, social function was measured using the Quality of Life Scale and stigma experience was assessed using the Internalized Stigma of Mental Illness Scale among 36 persons with schizophrenia at two points, 6 months apart. Correlations found stigma was associated with concurrent levels of positive and emotional discomfort symptoms and degree of social contact. When initial stigma levels were controlled for, stigma at 6 months was predicted by baseline levels of positive symptoms. Greater initial stigma predicted greater emotional discomfort at follow-up. Results suggest internalized stigma is linked with social function and symptoms. Positive symptoms may make some persons with schizophrenia more vulnerable to ongoing stigma experience.

Introduction

Population surveys indicate that, despite increased awareness of the nature of schizophrenia spectrum disorders (Swindle et al., 2000), many among the general public hold stereotyped beliefs about persons with these conditions including expectations of violent and disorderly behavior, and an inability to sustain employment or make informed decisions (Markowitz, 1998, Link et al., 1999, Pescosolido et al., 1999, Phelan et al., 2000). A matter of great importance, stigma may incline persons in the general public to seek social distance from those with schizophrenia (Angermeyer and Matschinger, 2003, Martin et al., 2000) and represent a barrier to meeting basic needs (Link et al., 1989, Wahl and Harman, 1989). Stigma can interfere, for instance, with obtaining work (Bordieri and Drehmner, 1986, Link, 1987), housing (Page, 1983) and/or negotiating with the legal system (Sosowski, 1980). Stigma may also possibly encourage persons to embrace self-fulfilling prophecies of failure (Ritsher et al., 2003, Ritsher and Phelan, 2004, Thompson, 1988, Warner et al., 1989, Wright et al., 2000) and has been suspected to be connected to suicide in schizophrenia (Siris, 2001).

While stigma against the mentally ill has been linked to decrements in role function and morale, it remains less clear whether stigma is linked with symptoms and interpersonal relations. Do certain symptoms or patterns of social function increase vulnerability to accepting stigmatizing beliefs? For instance, with heightened levels of positive or affective symptoms, do persons tend to be more accepting of stigma? Considering the converse: as persons increasingly internalize stigma, are they more likely to experience increases in symptoms or decrements in psychosocial function?

We suggest there are several reasons to speculate that stigma may influence and be influenced by symptoms and social relations over time. For one, stigma may drive persons away from society and incline them towards non-adherence to medication (e.g. Katschnig, 2000, Freudenreich et al., 2004, Lloyd et al., 2005). Such behavior can lead to a number of problems, both for the individual and in terms of others' perceptions. Torrey (2004) proposes that, while there is not a linear relationship between medication noncompliance and violent behavior, treatment non-adherence is related to violent behavior and such behavior perpetuates stigma of those with severe psychiatric disorders. Thus, perhaps as persons internalize stigma, they withdraw and with greater stress and fewer supports experience exacerbations in their symptoms. It is also possible to imagine that, as symptoms and/or social dysfunction reach a certain level, they may identify persons with schizophrenia as mentally ill to others, making them vulnerable to stigma. Perhaps too as persons become more symptomatic they despair and are more likely to accept negative beliefs about themselves. Therefore, as symptoms and dysfunction worsens perhaps, there is also greater internalization of stigma.

Research to date on the association of clinical features of illness and stigma has been limited and equivocal, however. Dickerson et al. (2002) found stigma experiences linked to socioeconomic factors but not with positive or negative symptoms. Ertugrul and Ulug (2004) compared groups of persons with schizophrenia who had more severe vs. less severe stigma experience and reported the more severely stigmatized group had more severe symptoms. Penn et al. (2000) found that negative symptoms predicted the experience of discriminatory behaviors.

One limitation of this research has been it's cross sectional nature. Furthermore, while measures of stigma assess stigma exposure, they do not necessarily assess the extent to which persons internalize or accept stigmatizing beliefs. To address these issues, we have assessed stigma using an instrument, which includes a measure of internalization of stigma and resulting alienation along with symptoms and social function at two points in time. We reasoned this approach would allow us to assess concurrent relationships at two separate times and to see effects between time points, controlling for baseline. Specifically, we examined two hypotheses: (a) would measures of symptoms and social function predict levels of stigma 6 months later, controlling for baseline stigma level and (b) would levels of stigma predict symptoms and social function 6 months later, controlling for baseline symptoms and social function.

Section snippets

Participants

Thirty-three males and three females with SCID (Spitzer et al., 1994) confirmed DSM-IV diagnoses of schizophrenia or schizoaffective disorder were recruited from a comprehensive day hospital at a VA Medical Center for a larger survey of the prevalence of anxiety symptoms in schizophrenia. All participants were receiving ongoing outpatient treatment and were in a post acute or stable phase of their disorder, defined as no hospitalizations or changes in medication or housing in the last month.

Results

Mean and standard deviations of ISMIS baseline scores were: alienation 1.39 (0.68), stereotype endorsement 1.14 (0.61), discrimination experience 1.42 (0.70), social withdrawal 1.31 (0.67) and stigma resistance 1.24 (0.50). Mean and standard deviations for PANSS and QOLS scores at baseline were: positive symptoms 17.22 (5.35), negative symptoms 17.5 (5.01), emotional discomfort 13.14 (4.56), interpersonal relations 19.72 (6.94) and intrapsychic foundations 22.17 (4.13). ISMIS scores were

Discussion

Results suggest that stigma experiences are associated with symptoms and social function. At baseline and 6 months, participants reporting more internalized stigma had higher levels of positive symptoms, more emotional discomfort and fewer social relationships. Higher levels of positive symptoms at baseline was a risk factor for greater internalized stigma 6 months later, even when controlling for stigma at baseline. Higher levels of internalized stigma at baseline were a risk factor for

References (32)

  • D.L. Penn et al.

    Interpersonal factors contributing to the stigma of schizophrenia: social skills perceived attractiveness and symptoms

    Schizophrenia Research

    (2000)
  • J.B. Ritsher et al.

    Internalized stigma predicts erosion of morale among psychiatric outpatients

    Psychiatry Research

    (2004)
  • M.C. Angermeyer et al.

    The stigma of mental illness: effects of labeling on public attitudes towards people with mental disorder

    Acta Psychiatrica Scandinavica

    (2003)
  • M.D. Bell et al.

    Five-component model of schizophrenia: assessing the factorial invariance of the PANSS

    Psychiatry Research

    (1993)
  • J. Bordieri et al.

    Hiring decisions for disabled workers: looking at the cause

    Journal of Applied Social Psychology

    (1986)
  • F.B. Dickerson et al.

    Experiences of stigma among outpatients with schizophrenia

    Schizophrenia Bulletin

    (2002)
  • A. Ertugrul et al.

    The influence of neurocognitive deficits and symptoms on disability in schizophrenia

    Acta Psychiatrica Scandinavica

    (2002)
  • A. Ertugrul et al.

    Perception of stigma among patients with schizophrenia

    Social Psychiatry and Psychiatric Epidemiology

    (2004)
  • O. Freudenreich et al.

    Attitudes of schizophrenia outpatients towards psychiatric medications: relationship to clinical variables and insight

    Journal of Clinical Psychiatry

    (2004)
  • D.W. Heinrichs et al.

    The Quality of Life Scale: an instrument for assessing the schizophrenic deficit syndrome

    Schizophrenia Bulletin

    (1984)
  • H. Katschnig

    Schizophrenia and quality of life

    Acta Psychiatrica Scandinavica

    (2000)
  • S.R. Kay et al.

    The Positive and Negative Syndrome Scale for schizophrenia

    Schizophrenia Bulletin

    (1987)
  • B.G. Link

    Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejections

    American Sociological Review

    (1987)
  • B.G. Link et al.

    A modified labeling theory approach to mental disorders: an empirical assessment

    American Sociological Review

    (1989)
  • B.G. Link et al.

    Public conceptions of mental illness: labels, causes, dangerousness and social distance

    American Journal of Public Health

    (1999)
  • C. Lloyd et al.

    Perceptions of social stigma and its effect on interpersonal relationships of young males who experience a psychotic disorder

    Australian Occupational Therapy Journal

    (2005)
  • Cited by (167)

    • The clinical and psychosocial correlates of self-stigma among people with schizophrenia spectrum disorders across cultures: A systematic review and meta-analysis

      2022, Schizophrenia Research
      Citation Excerpt :

      Individuals with SSD are at heightened risk of experiencing higher and more intense levels of self-stigma and public stigma compared to individuals with other mental illnesses (Crisp et al., 2000; Dinos et al., 2004; Holzinger et al., 2003; Karidi et al., 2015; Wood et al., 2014). These findings are problematic given that self-stigma was associated with adverse clinical and psychosocial outcomes such as lower self-esteem, quality of life, and hope, impaired recovery, poorer social/vocational function and treatment adherence, as well as greater symptom severity, distress, dysfunctional attitudes, depression, and avoidant coping style (Corrigan and Watson, 2002; Dubreucq et al., 2021; Livingston and Boyd, 2010; Lysaker et al., 2007a; Margetić et al., 2010; Park et al., 2013; Schrank et al., 2014; Yanos et al., 2008, 2010). Furthermore, Yanos et al. (2020) found support – across subpopulations, geographic location, and method – for various components of the “Illness Identity” model, which proposed that self-stigma impacts hope and self-esteem and subsequently leads to negative effects on recovery-related outcomes among people with mental illnesses.

    View all citing articles on Scopus
    View full text